
Cytek Biosciences Inc
NASDAQ:CTKB

Intrinsic Value
The intrinsic value of one
CTKB
stock under the Base Case scenario is
4.81
USD.
Compared to the current market price of 3.37 USD,
Cytek Biosciences Inc
is
Undervalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Cytek Biosciences Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Cytek Biosciences Inc
Balance Sheet Decomposition
Cytek Biosciences Inc
Current Assets | 380.5m |
Cash & Short-Term Investments | 265.6m |
Receivables | 55.2m |
Other Current Assets | 59.7m |
Non-Current Assets | 102.1m |
PP&E | 27.7m |
Intangibles | 36.1m |
Other Non-Current Assets | 38.3m |
Free Cash Flow Analysis
Cytek Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Cytek Biosciences Inc
Revenue
|
197.1m
USD
|
Cost of Revenue
|
-88.8m
USD
|
Gross Profit
|
108.3m
USD
|
Operating Expenses
|
-133m
USD
|
Operating Income
|
-24.8m
USD
|
Other Expenses
|
13.5m
USD
|
Net Income
|
-11.3m
USD
|
CTKB Profitability Score
Profitability Due Diligence
Cytek Biosciences Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Score
Cytek Biosciences Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
CTKB Solvency Score
Solvency Due Diligence
Cytek Biosciences Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Score
Cytek Biosciences Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CTKB Price Targets Summary
Cytek Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
CTKB
is 5.87 USD
with a low forecast of 4.04 USD and a high forecast of 8.4 USD.
Dividends
Current shareholder yield for CTKB is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CTKB
stock under the Base Case scenario is
4.81
USD.
Compared to the current market price of 3.37 USD,
Cytek Biosciences Inc
is
Undervalued by 30%.